Caprolactam Chemicals Ltd
Caprolactam Chemicals Ltd (CAPRO) last reported results for the quarter ended Jun 2026, with sales of ₹0.47 crore and net profit of ₹-0.99 crore. The stock last traded at ₹46, a market capitalisation of ₹21.2 crore, on a P/E of 50.4. Over the past 52 weeks the stock has ranged between ₹37.1 and ₹81. Figures are as of 9 Oct 2026 and are not real time.
Caprolactam Chemicals Ltd share price and key metrics
- Current price
- ₹46
- Market cap
- ₹21.2 cr
- Stock P/E
- 50.4
- Book value
- ₹14.3
- ROE
- 30.3%
- ROCE
- 19.6%
- Dividend yield
- 0.00%
- 52w high / low
- 81.0/37.1
Metrics as of 9 Oct 2026. Not real time.
Track Caprolactam Chemicals Ltd
Cruxal reads every Caprolactam Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Caprolactam Chemicals Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 11%
- 3 Years
- 2%
- TTM
- 4%
- 10 Years
- 13%
- 5 Years
- 22%
- 3 Years
- -12%
- TTM
- 625%
- 10 Years
- 16%
- 5 Years
- -8%
- 3 Years
- -13%
- 1 Year
- 2%
- 10 Years
- 13%
- 5 Years
- 10%
- 3 Years
- 7%
- Last Year
- 30%
Caprolactam Chemicals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0.47 cr, down 81.6% from ₹2.56 cr a year earlier. Net profit swung to a loss of ₹0.99 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1.71 | 2.29 | 1.61 | 2.56 | 2.36 | 2.56 | 3.07 | 0.47 |
| Expenses | 1.14 | 1.82 | 1.38 | 1.51 | 1.7 | 1.45 | 1.42 | 0.91 |
| Operating profit | 0.57 | 0.47 | 0.23 | 1.05 | 0.66 | 1.11 | 1.65 | -0.44 |
| OPM % | 33.33% | 20.52% | 14.29% | 41.02% | 27.97% | 43.36% | 53.75% | -93.62% |
| Other income | 0 | 0.01 | 0 | 0 | 0.02 | 0 | 0.01 | 0 |
| Interest | 0.14 | 0.17 | 0.18 | 0.18 | 0.19 | 0.18 | 0.17 | 0.18 |
| Depreciation | 0.4 | 0.4 | 0.41 | 0.38 | 0.39 | 0.41 | 0.44 | 0.37 |
| Profit before tax | 0.03 | -0.09 | -0.36 | 0.49 | 0.1 | 0.52 | 1.05 | -0.99 |
| Tax % | 0.00% | -66.67% | 25.00% | 24.49% | -20.00% | 17.31% | 20.00% | 0.00% |
| Net profit | 0.04 | -0.03 | -0.45 | 0.36 | 0.13 | 0.44 | 0.84 | -0.99 |
| EPS (₹) | 0.09 | -0.07 | -0.98 | 0.78 | 0.28 | 0.96 | 1.83 | -2.15 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Caprolactam Chemicals Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.23 | 4.07 | 5.19 | 6.51 | 6.31 | 2.07 | 9.84 | 6.96 | 6.74 | 10.56 | 8.46 |
| Operating profit | 0.47 | 0.89 | 1.88 | 2.52 | 2.17 | -0.57 | 4.67 | 2.17 | 1.59 | 4.47 | 2.98 |
| OPM % | 14.55% | 21.87% | 36.22% | 38.71% | 34.39% | -27.54% | 47.46% | 31.18% | 23.59% | 42.33% | 35.22% |
| Net profit | -0.12 | 0.17 | 0.5 | 0.95 | 0.65 | -1.28 | 2.55 | 0.2 | -0.71 | 1.76 | 0.42 |
| EPS (₹) | -0.26 | 0.37 | 1.09 | 2.07 | 1.41 | -2.78 | 5.54 | 0.43 | -1.54 | 3.83 | 0.92 |
TTM is the trailing twelve months to the most recent quarter.
Caprolactam Chemicals Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4.59 | 4.59 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
| Reserves | -2.73 | -2.56 | -2.06 | -1.10 | -0.52 | -1.80 | 0.74 | 0.95 | 0.23 | 1.98 |
| Borrowings | 1.37 | 1.89 | 3.58 | 2.45 | 2.15 | 3.76 | 5.69 | 5.86 | 8.72 | 9.23 |
| Other liabilities | 1.10 | 2.35 | 1.29 | 1.16 | 0.97 | 3.77 | 0.49 | 0.25 | 0.74 | 1.23 |
| Total liabilities | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.66 | 14.29 | 17.04 |
| Fixed assets | 3.38 | 3.56 | 6.37 | 6.07 | 5.50 | 5.26 | 10.22 | 10.29 | 10.31 | 10.16 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 0.95 | 2.71 | 1.04 | 1.04 | 1.70 | 1.11 | 1.30 | 1.37 | 3.98 | 6.88 |
| Total assets | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.66 | 14.29 | 17.04 |
As reported by the company. Total assets equal total liabilities by construction.
Caprolactam Chemicals Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0.54 | 1.10 | 2.96 | 2.18 | 1.25 | 3.05 | 0.86 | 1.82 | -0.56 | 1.65 |
| Cash from investing | -0.89 | -0.75 | -3.78 | -0.73 | -0.48 | -4.75 | -2.14 | -1.64 | -1.60 | -1.41 |
| Cash from financing | 0.30 | 0.33 | 0.35 | -1.43 | -0.59 | 1.33 | 1.37 | -0.32 | 2.16 | -0.23 |
| Net cash flow | -0.05 | 0.68 | -0.47 | 0.02 | 0.18 | -0.37 | 0.08 | -0.14 | 0.00 | 0.00 |
| Free cash flow | -0.35 | 0.34 | -0.82 | 1.45 | 0.76 | -1.70 | -1.30 | 0.17 | -2.17 | 0.22 |
| CFO / operating profit | 115% | 128% | 164% | 92% | 80% | -591% | 27% | 88% | -35% | 39% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Caprolactam Chemicals Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 0.32% | 10.91% | 19.52% | 25.85% | 19.54% | -18.61% | 40.25% | 6.86% | -0.40% | 19.55% |
| Debtor days | 40.68 | 69.05 | 2.81 | 16.82 | 27.19 | 5.29 | 25.22 | 33.56 | 152.72 | 214.64 |
| Inventory days | — | 304.17 | 88.78 | — | — | 82.64 | 53.85 | 52.14 | 111.68 | 65.62 |
| Days payable | — | 861.81 | 799.05 | — | — | 344.34 | 173.52 | 111.73 | 119.85 | 209.16 |
| Cash conversion cycle | 40.68 | -488.58 | -707.46 | 16.82 | 27.19 | -256.41 | -94.45 | -26.03 | 144.54 | 71.11 |
| Working capital days | -169.50 | -232.27 | -274.28 | -158.11 | -106.43 | -689.44 | -94.22 | -267.46 | -314.64 | -133.76 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Caprolactam Chemicals Ltd shareholding pattern
Promoters held 54.50% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.97% | 53.99% | 54.02% | 54.04% | 54.05% | 54.50% | 54.50% | 54.50% |
| Public | 46.03% | 46.00% | 45.97% | 45.95% | 45.94% | 45.50% | 45.49% | 45.49% |
| No. of shareholders | 8,219 | 8,240 | 8,180 | 8,158 | 8,142 | 8,068 | 8,001 | 7,992 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Caprolactam Chemicals Ltd corporate filings
- Compliance Certificate under of Reg 74 (5)Company Updatelow impact
- Caprolactam Chemicals Limited appoints M/s. Raman S. Shah & Co. as Statutory Auditors for 5-year term from FY2026-27 to FY2030-31Company Updatelow impact
Cruxal's analysis: Caprolactam Chemicals Limited has announced the appointment of M/s. Raman S. Shah & Co…
Read the full analysis - Consolidated Report of the ScrutinizerAGM/EGMmedium impact
- Closure of trading windowInsider Trading / SASTlow impact
- Caprolactam Chemicals Limited concludes 37th Annual General Meeting; appoints new statutory auditorsAGM/EGMlow impact
Cruxal's analysis: Caprolactam Chemicals Limited has successfully concluded its 37th Annual General Meeting…
Read the full analysis - Caprolactam Chemicals Ltd. Announces Change in Internal AuditorCompany Updatelow impact
Cruxal's analysis: Caprolactam Chemicals Ltd. has announced the resignation of its internal auditor, M/s…
Read the full analysis - Caprolactam Chemicals Ltd: Routine newspaper publication of financial results complianceCompany Updatelow impact
Cruxal's analysis: Caprolactam Chemicals Ltd has fulfilled its statutory obligation under Regulations 30 and…
Read the full analysis - Caprolactam Chemicals Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Caprolactam Chemicals Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Caprolactam Chemicals Limited announces 37th Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Caprolactam Chemicals Limited has issued a notice for its 37th Annual General Meeting…
Read the full analysis - Caprolactam Chemicals Ltd. Announces Board Approval for 37th AGM and Appointment of New Statutory AuditorOtherslow impact
Cruxal's analysis: Caprolactam Chemicals Ltd. has formally scheduled its 37th Annual General Meeting for…
Read the full analysis - Caprolactam Chemicals Ltd. Reports Significant Quarterly Loss for June 2026Company Updatehigh impact
Cruxal's analysis: Caprolactam Chemicals Ltd. has released its unaudited financial results for the quarter…
Read the full analysis - Caprolactam Chemicals reports significant Q1 FY27 loss of 98.86 lakh amid sharp revenue contractionBoard Meetinghigh impact
Cruxal's analysis: Caprolactam Chemicals Limited reported a weak performance for the quarter ended June 30…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.